U.S. Markets open in 9 hrs 1 mins

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
319.00+1.07 (+0.34%)
At close: 4:00PM EDT
People also watch
CELGREGNGILDAMGNALXN
Full screen
Previous Close317.93
Open318.61
Bid279.26 x 100
Ask400.00 x 100
Day's Range316.52 - 321.60
52 Week Range244.28 - 330.00
Volume849,480
Avg. Volume1,360,978
Market Cap67.45B
Beta0.50
PE Ratio (TTM)20.93
EPS (TTM)15.24
Earnings DateOct 24, 2017 - Oct 30, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est333.02
Trade prices are not sourced from all markets
  • Benzinga14 hours ago

    Biogen Spinoff Bioverativ Is A Buy

    Analysts at Argus Research turned bullish on Bioverativ Inc (NASDAQ: BIVV ) as the company could establish itself as a profitable biotech within the hemophilia and blood disorders space. The firm's Jasper ...

  • See what the IHS Markit Score report has to say about Biogen Inc.
    Markit16 hours ago

    See what the IHS Markit Score report has to say about Biogen Inc.

    This could indicate that investors who seek to profit from falling equity prices are not currently targeting BIIB. Over the last one-month, outflows of investor capital in ETFs holding BIIB totaled $1.03 billion.

  • Profit From the Biogen Inc (BIIB) Stock Dip!
    InvestorPlace2 days ago

    Profit From the Biogen Inc (BIIB) Stock Dip!

    Biogen Inc (NASDAQ:BIIB) stock had a fantastic start to September with a 15% rally. Clearly, this is a momentum stock, so it will never give us a clear signal for entry. More often than not, traders tend to overshoot with the price action of momentum stocks.